Cary Street Partners Investment Advisory LLC Sells 19,026 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cary Street Partners Investment Advisory LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 92.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,517 shares of the healthcare conglomerate’s stock after selling 19,026 shares during the quarter. Cary Street Partners Investment Advisory LLC’s holdings in UnitedHealth Group were worth $762,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in UNH. Richelieu Gestion SA purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $26,000. Robbins Farley purchased a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $25,000. CGC Financial Services LLC raised its holdings in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares in the last quarter. NewSquare Capital LLC raised its holdings in shares of UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA raised its holdings in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Stephens restated an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a report on Thursday, February 8th. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Wells Fargo & Company decreased their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a report on Monday, April 8th. Deutsche Bank Aktiengesellschaft increased their target price on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Finally, Morgan Stanley reduced their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Price Performance

UNH opened at $483.70 on Wednesday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The business’s fifty day simple moving average is $484.44 and its 200-day simple moving average is $513.42. The company has a market capitalization of $445.04 billion, a price-to-earnings ratio of 29.57, a PEG ratio of 1.42 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter last year, the company earned $6.26 earnings per share. The firm’s revenue for the quarter was up 8.6% compared to the same quarter last year. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 45.97%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.